GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » MDxHealth SA (NAS:MDXH) » Definitions » Short-Term Debt

MDxHealth (MDxHealth) Short-Term Debt : $0.64 Mil (As of Sep. 2023)


View and export this data going back to 2008. Start your Free Trial

What is MDxHealth Short-Term Debt?

MDxHealth's Short-Term Debt for the quarter that ended in Sep. 2023 was $0.64 Mil.

MDxHealth's quarterly Short-Term Debt increased from Mar. 2023 ($0.62 Mil) to Jun. 2023 ($0.64 Mil) and increased from Jun. 2023 ($0.64 Mil) to Sep. 2023 ($0.64 Mil).

MDxHealth's annual Short-Term Debt increased from Dec. 2020 ($2.82 Mil) to Dec. 2021 ($4.44 Mil) but then declined from Dec. 2021 ($4.44 Mil) to Dec. 2022 ($0.62 Mil).

MDxHealth Short-Term Debt Historical Data

The historical data trend for MDxHealth's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MDxHealth Short-Term Debt Chart

MDxHealth Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.57 2.82 4.44 0.62

MDxHealth Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 0.62 0.62 0.64 0.64

MDxHealth Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

MDxHealth Short-Term Debt Related Terms

Thank you for viewing the detailed overview of MDxHealth's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

MDxHealth (MDxHealth) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » MDxHealth SA (NAS:MDXH) » Definitions » Short-Term Debt
Comparable Companies
BIOQ PSNL VNRX PRE ENZ PRPH ACRS BNR DRIO AWH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT
Traded in Other Exchanges
N/A
Address
Rue d’Abhooz, 31, Cap Business Center, Herstal, Liege, BEL, 4040
Website
https://www.mdxhealth.com
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.